Quantcast

Latest stroke Stories

2014-10-01 08:32:44

Commercial activities ahead of schedule following release of strong clinical data in the multi-specialty CARENET trial BOSTON, Oct. 1, 2014 /PRNewswire/ -- InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems (EPS), today announced that it has recorded the first commercial sales of the CGuard(TM) carotid EPS. The Company accelerated the limited market release (LMR) of the CGuard based on strong interest created by the recent positive...

2014-09-30 23:04:54

Icahn School of Medicine at Mount Sinai research findings show there was no significant difference in 15-year survival or stroke rates in patients aged between 50 and 69 years who had aortic valve replacement with bioprosthetic valves compared with mechanical valves. New York, NY (PRWEB) September 30, 2014 New Icahn School of Medicine at Mount Sinai research findings published in the October 1 issue of JAMA show there was no significant difference in 15-year survival or stroke rates in...

2014-09-30 16:28:29

Stroke Survivor will Focus on Building Awareness and Strategic Growth to Expand Organization's 30-Year Legacy CENTENNIAL, Colo., Sept. 30, 2014 /PRNewswire-USNewswire/ -- National Stroke Association, the only national nonprofit dedicated 100 percent to stroke, has appointed veteran business and marketing executive Matt Lopez as CEO. Lopez brings 20 years leadership and business experience working with national and global markets and international brands. Lopez has held a variety...

2014-09-30 12:27:22

LEXINGTON, Ky., Sept. 30, 2014 /PRNewswire-USNewswire/ -- A study using a relatively new imaging tool, optical coherence tomography (OCT), offered a new look at the composition of carotid artery disease and has the potential to alter how physicians understand and treat the disease, a leading cause of stroke. The study, conducted at Baptist Health Lexington between September 2010 and May 2012, was featured in the June 2014 issue of the Journal of the American College of Cardiology...

2014-09-30 08:33:16

DALLAS, Sept. 30, 2014 /PRNewswire/ -- September is Atrial Fibrillation Awareness Month, and as the most prominent atrial fibrillation patient organization, StopAfib.org has added some prestigious healthcare professionals to its Global Medical Advisory Board. Photo - http://photos.prnewswire.com/prnh/20140929/149190 Photo - http://photos.prnewswire.com/prnh/20140929/149191 Atrial fibrillation, also known as afib, is the most common irregular heartbeat and can lead to dementia,...

2014-09-29 16:25:38

AMBLER, Pa., Sept. 29, 2014 /PRNewswire/ -- Moberg (www.moberg.com) has received CE Mark approval for the CNS Monitor, a medical device used for advanced monitoring of neurological intensive care patients. The CE Mark certifies that a product has met European Union requirements for commercial marketing in Europe. The CNS Monitor captures and analyzes multiple physiologic parameters including electroencephalography (EEG, or brain waves) to support neurological patient care. The...

2014-09-29 08:31:40

Additional New Features Help Patients and Physicians Monitor and Manage Heart Health SAN FRANCISCO, Sept. 29, 2014 /PRNewswire/ -- AliveCor, Inc. announced today the launch of the latest version of the AliveECG app, which provides patients with free real-time atrial fibrillation (AF) detection in ECG recordings using its new FDA-cleared algorithm. The new app helps patients and physicians manage existing conditions with intelligent, personalized and easy-to-use new features. Tracking...

2014-09-28 23:02:43

Wright & Schulte LLC Continues To Investigate Complaints That Janssen Pharmaceuticals Did Not Disclose The Lack of An Effective Means To Treat Uncontrolled Bleeding In Patients Taking Xarelto Columbus, OH (PRWEB) September 28, 2014 Wright & Schulte LLC has learned that a Xarelto bleeding lawsuit complaint was filed on behalf of a California woman who alleges that she suffered life-threatening bleeding as a result of taking the blood thinner medication. According to the Xarelto...

2014-09-26 08:25:09

TOKYO, Sept. 26, 2014 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it received approval from the Ministry of Health, Labour and Welfare in Japan for LIXIANA(® )(JAN: Edoxaban Tosilate Hydrate, INN: edoxaban) for the prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF) and for the treatment and recurrence prevention of venous thromboembolism (VTE) [deep vein thrombosis (DVT) and...

2014-09-26 04:21:23

OSAKA, Japan, Sept. 26, 2014 /PRNewswire/ -- Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo Dainippon Pharma") and SanBio Co., Ltd., acting through its U.S. subsidiary SanBio, Inc. ("SanBio"), announced on September 26 that the two companies have entered into a joint development and license agreement for exclusive marketing rights in the U.S. and Canada ("Agreement") for SB623, a cell therapy for the treatment of patients with chronic stroke discovered and currently under development...


Latest stroke Reference Libraries

Stroke
2012-05-02 19:35:56

Stroke is a peer-reviewed medical journal published monthly by Lippincott Williams & Wilkins on behalf of the American Heart Association. As of May 2012, the current editor-in-chief is Marc Fisher (University of Massachusetts Medical School). Stroke covers research on cerebral circulation and related diseases, including clinical research on assessment of risk for stroke, diagnosis, prevention, and treatment, as well as rehabilitation. The audience base for Stroke includes neurologists,...

More Articles (1 articles) »
Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related